-
EU Drug Regulator Recommends Adding ‘Heavy Menstrual Bleeding’ as mRNA COVID-19 Vaccine Side-Effect -
EU Approves Pfizer’s COVID-19 Pill for Adults at Risk of Severe Disease -
EU Regulator Backs Giving J&J Booster Shot to Adults 2 Months After Initial Dose -
EU Regulator Backs Giving COVID-19 Shots to Children Aged 5 to 11 -
EU Regulator Backs Pfizer Booster Shots for People 18 and Older -
EU Regulator Unable to Confirm If Women Face Increased Clot Risks After AstraZeneca Shot -
EMA Official Says AstraZeneca Shots Have Good Risk-Benefit Profile for Over 60s -
Norway Should Exclude J&J, AstraZeneca From Vaccine Scheme: Panel -
Pfizer, BioNTech Seek EU’s OK to Use COVID-19 Vaccine on Kids -
UK Survey Finds Rising Unease About AstraZeneca COVID-19 Vaccine -
UK Death Toll From Blood Clots After AstraZeneca Jab Rises to 19 -
Clear Link Between AstraZeneca Vaccine and Rare Blood Clots in Brain, EMA Official Tells Paper -
Germany Reports More Blood Clot Cases Associated With AstraZeneca Vaccine -
EU May Exclude China-Made Vaccines as Vietnam Looks Elsewhere -
Why a ‘Miracle’ Drug Exists but You Can’t Have It Yet